PortfoliosLab logoPortfoliosLab logo
MDEV vs. IDNA
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

MDEV vs. IDNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in First Trust Indxx Medical Devices ETF (MDEV) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MDEV achieves a -11.48% return, which is significantly lower than IDNA's 10.31% return.


MDEV

1D
0.04%
1M
1.54%
YTD
-11.48%
6M
-12.29%
1Y
-7.05%
3Y*
-2.86%
5Y*
10Y*

IDNA

1D
0.73%
1M
-2.56%
YTD
10.31%
6M
8.52%
1Y
40.87%
3Y*
6.74%
5Y*
-8.42%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

MDEV vs. IDNA - Yearly Performance Comparison


2026 (YTD)20252024202320222021
MDEV
First Trust Indxx Medical Devices ETF
-11.48%2.00%1.79%7.55%-28.59%4.16%
IDNA
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund
10.31%17.26%-0.72%-7.63%-42.28%-10.15%

Correlation

The correlation between MDEV and IDNA is 0.55, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.55

Correlation (3Y)
Calculated over the trailing 3-year period

0.58

Correlation (All Time)
Calculated using the full available price history since Jun 24, 2021

0.64

The correlation between MDEV and IDNA has been stable across timeframes, ranging from 0.55 to 0.64 - a consistent structural relationship.

MDEV vs. IDNA - Sectors Allocation Comparison


Sectors
MDEV
IDNA

Healthcare

100.0%
97.8%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

-

Industrials

-

0.4%

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

MDEV
100.0%
IDNA
97.8%

Basic Materials

MDEV

-

IDNA

-

Communication Services

MDEV

-

IDNA

-

Consumer Cyclical

MDEV

-

IDNA

-

Consumer Defensive

MDEV

-

IDNA

-

Energy

MDEV

-

IDNA

-

Financial Services

MDEV

-

IDNA

-

Industrials

MDEV

-

IDNA
0.4%

Real Estate

MDEV

-

IDNA

-

Technology

MDEV

-

IDNA

-

Utilities

MDEV

-

IDNA

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MDEV vs. IDNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MDEV
MDEV Risk / Return Rank: 55
Overall Rank
MDEV Sharpe Ratio Rank: 55
Sharpe Ratio Rank
MDEV Sortino Ratio Rank: 55
Sortino Ratio Rank
MDEV Omega Ratio Rank: 55
Omega Ratio Rank
MDEV Calmar Ratio Rank: 55
Calmar Ratio Rank
MDEV Martin Ratio Rank: 44
Martin Ratio Rank

IDNA
IDNA Risk / Return Rank: 5555
Overall Rank
IDNA Sharpe Ratio Rank: 4848
Sharpe Ratio Rank
IDNA Sortino Ratio Rank: 4949
Sortino Ratio Rank
IDNA Omega Ratio Rank: 4242
Omega Ratio Rank
IDNA Calmar Ratio Rank: 7676
Calmar Ratio Rank
IDNA Martin Ratio Rank: 6161
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MDEV vs. IDNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for First Trust Indxx Medical Devices ETF (MDEV) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MDEVIDNADifference
Sharpe ratioReturn per unit of total volatility

-2.12

Sortino ratioReturn per unit of downside risk

-2.96

Omega ratioGain probability vs. loss probability

0.94

1.27

-0.33

Calmar ratioReturn relative to maximum drawdown

-0.39

3.85

-4.24

Martin ratioReturn relative to average drawdown

-0.98

10.98

-11.96

MDEV vs. IDNA - Sharpe Ratio Comparison

The current MDEV Sharpe Ratio is -0.44, which is lower than the IDNA Sharpe Ratio of 1.68. The chart below compares the historical Sharpe Ratios of MDEV and IDNA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


MDEVIDNADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.44

1.68

-2.12

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.30

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.32

0.10

-0.42

Drawdowns

MDEV vs. IDNA - Drawdown Comparison

The maximum MDEV drawdown since its inception was -42.34%, smaller than the maximum IDNA drawdown of -68.26%. Use the drawdown chart below to compare losses from any high point for MDEV and IDNA.


Loading charts...

Drawdown Indicators


MDEVIDNADifference

Max Drawdown

Largest peak-to-trough decline

-42.34%

-68.26%

+25.92%

Max Drawdown (1Y)

Largest decline over 1 year

-18.13%

-10.66%

-7.47%

Max Drawdown (3Y)

Largest decline over 3 years

-22.50%

-29.73%

+7.23%

Max Drawdown (5Y)

Largest decline over 5 years

-68.26%

Current Drawdown

Current decline from peak

-33.76%

-45.61%

+11.85%

Average Drawdown

Average peak-to-trough decline

-25.65%

-36.24%

+10.59%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.22%

3.73%

+3.49%

Volatility

MDEV vs. IDNA - Volatility Comparison

The current volatility for First Trust Indxx Medical Devices ETF (MDEV) is 4.60%, while iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) has a volatility of 7.18%. This indicates that MDEV experiences smaller price fluctuations and is considered to be less risky than IDNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MDEVIDNADifference

Volatility (1M)

Calculated over the trailing 1-month period

4.60%

7.18%

-2.58%

Volatility (6M)

Calculated over the trailing 6-month period

11.42%

17.98%

-6.56%

Volatility (1Y)

Calculated over the trailing 1-year period

16.00%

24.48%

-8.48%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

18.98%

28.42%

-9.44%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.98%

29.53%

-10.55%

MDEV vs. IDNA - Expense Ratio Comparison

MDEV has a 0.70% expense ratio, which is higher than IDNA's 0.47% expense ratio.


Dividends

MDEV vs. IDNA - Dividend Comparison

MDEV has not paid dividends to shareholders, while IDNA's dividend yield for the trailing twelve months is around 1.07%.


PositionTTM2025202420232022202120202019
IDNA
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund
1.07%1.18%0.98%1.04%0.54%0.70%0.26%0.80%
MDEV
First Trust Indxx Medical Devices ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


MDEV and IDNA have a correlation of 0.55, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IDNA has higher volatility (7.18%) compared to MDEV (4.60%). In terms of maximum drawdown, MDEV dropped -42.34% vs IDNA's -68.26%.

On 3-year performance, IDNA leads with 6.74% vs -2.86% for MDEV. On fees, IDNA is cheaper at 0.47% per year. On volatility, MDEV has been the lower-risk option at 4.60%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 3-year period, IDNA has performed better with a 6.74% return vs -2.86%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

IDNA is cheaper with a 0.47% expense ratio, compared with 0.70% for MDEV.

IDNA has the higher dividend yield at 1.07%, compared with 0.00% for MDEV.

MDEV tracks Indxx Global Medical Equipment Index, while IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index. They also come from different issuers: First Trust and iShares. Their fees differ too: 0.70% for MDEV and 0.47% for IDNA.

IDNA currently has the higher Sharpe Ratio (1.68 vs -0.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MDEV and IDNA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer